One obvious difference between the datasets, which may in part explain the discrepancy, is that 71% of the TAM-treated tumours in the GOBO data were ER+/LN− at diagnosis, compared with only 35% of the TCGA TMA-treated tumours. Here, ESR1 is linked to neoplasm.